Kamioka Norihiko, Patel Ateet, Burke Michael A, Greenbaum Adam, Babaliaros Vasilis
Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.
Division of Cardiology, Henry Ford Health System, Detroit, Michigan.
Catheter Cardiovasc Interv. 2019 May 1;93(6):E343-E345. doi: 10.1002/ccd.27103. Epub 2017 May 22.
Impella (Abiomed, Danvers, MA) is an effective option for emergent treatment of critical refractory cardiogenic shock. However, in patients who have inadequate peripheral arterial access, Impella for left ventricular support sometimes requires surgical access, leading to disadvantages for emergent procedures or invasiveness for very sick patients. In addition, Impella for right ventricular support was recently reported to contribute to the management of severe biventricular dysfunction. In this report, we describe a case of refractory cardiogenic shock in a patient with inadequate vascular access who was treated with biventricular Impella via venous and caval-aortic access under conscious sedation. This technique can be used as a bridge to surgical ventricular assist device or heart transplantation. © 2017 Wiley Periodicals, Inc.
Impella(阿比奥梅德公司,马萨诸塞州丹弗斯)是危急难治性心源性休克紧急治疗的有效选择。然而,对于外周动脉通路不佳的患者,用于左心室支持的Impella有时需要手术通路,这给紧急手术带来不利影响,或对病情非常严重的患者造成侵入性伤害。此外,最近有报道称用于右心室支持的Impella有助于严重双心室功能障碍的治疗。在本报告中,我们描述了1例血管通路不佳的难治性心源性休克患者,在清醒镇静下通过静脉和腔静脉-主动脉通路使用双心室Impella进行治疗的病例。该技术可作为通向手术心室辅助装置或心脏移植的桥梁。© 2017威利期刊公司